Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
MetLife
MET
|
+$797M |
| 4 |
Chevron
CVX
|
+$491M |
| 5 |
Applied Materials
AMAT
|
+$471M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$937M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$706M |
| 3 |
Gilead Sciences
GILD
|
+$618M |
| 4 |
IBM
IBM
|
+$567M |
| 5 |
AstraZeneca
AZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.15% |
| 2 | Financials | 14.08% |
| 3 | Technology | 12.63% |
| 4 | Energy | 11.41% |
| 5 | Industrials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MWV
1351
DELISTED
MEADWESTVACO CORP
MWV
| $7.17M | ﹤0.01% |
162,108
+146,890
| +965% | +$5.96M |
|
1352
Canadian Solar
CSIQ
$1.06B
| $7.1M | ﹤0.01% |
+227,023
| New | +$6.12M |
|
1353
SK Telecom
SKM
$12.8B
| $7.07M | ﹤0.01% |
165,319
-3,629
| -2% | -$141K |
|
1354
EastGroup Properties
EGP
$10.9B
| $7.04M | ﹤0.01% |
109,639
-49,018
| -31% | -$3.11M |
|
|
EPZM
1355
DELISTED
Epizyme, Inc
EPZM
| $7M | ﹤0.01% |
225,051
+15,270
| +7% | +$360K |
|
1356
Arrowhead Research
ARWR
$12.4B
| $6.88M | ﹤0.01% |
+480,990
| New | +$6.31M |
|
1357
CONMED
CNMD
$1.49B
| $6.81M | ﹤0.01% |
154,341
+4,390
| +3% | +$199K |
|
|
SRC
1358
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $6.78M | ﹤0.01% |
+133,166
| New | +$6.61M |
|
1359
Enovis
ENOV
$1.44B
| $6.78M | ﹤0.01% |
52,836
-31,847
| -38% | -$3.98M |
|
|
MBRG
1360
DELISTED
Middleburg Financial Corp
MBRG
| $6.77M | ﹤0.01% |
338,384
+3,484
| +1% | +$63.4K |
|
|
PGNX
1361
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $6.76M | ﹤0.01% |
1,569,104
+23,490
| +2% | +$89.7K |
|
|
AMAG
1362
DELISTED
AMAG Pharmaceuticals
AMAG
| $6.76M | ﹤0.01% |
326,060
+34,300
| +12% | +$634K |
|
1363
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $6.72M | ﹤0.01% |
129,965
+25,945
| +25% | +$1.32M |
|
|
VLRS
1364
Controladora Vuela Compania de Aviacion
VLRS
$928M
| $6.69M | ﹤0.01% |
743,761
-837,475
| -53% | -$6.61M |
|
1365
Korea Electric Power
KEP
$15.8B
| $6.68M | ﹤0.01% |
363,287
+1,727
| +0.5% | +$33.2K |
|
1366
Neonode
NEON
$17M
| $6.66M | ﹤0.01% |
212,806
-65,990
| -24% | -$2.86M |
|
1367
Ultralife
ULBI
$113M
| $6.64M | ﹤0.01% |
1,729,841
| – | – |
|
1368
MiMedx Group
MDXG
$622M
| $6.63M | ﹤0.01% |
934,716
-54,025
| -5% | -$316K |
|
1369
Crown Crafts
CRWS
$32.1M
| $6.63M | ﹤0.01% |
850,568
-4,500
| -0.5% | -$37.5K |
|
|
PRCP
1370
DELISTED
Perceptron Inc
PRCP
| $6.62M | ﹤0.01% |
519,294
| – | – |
|
1371
Vipshop
VIPS
$7.47B
| $6.6M | ﹤0.01% |
+351,750
| New | +$5.64M |
|
1372
Telus
TU
$15.2B
| $6.59M | ﹤0.01% |
353,408
+165,578
| +88% | +$3.03M |
|
|
SANW
1373
DELISTED
S&W Seed Co
SANW
| $6.58M | ﹤0.01% |
53,341
-1,406
| -3% | -$186K |
|
|
QVCGA
1374
DELISTED
QVC Group Inc Series A
QVCGA
| $6.57M | ﹤0.01% |
5,449
-9,394
| -63% | -$11.2M |
|
|
PFSW
1375
DELISTED
PFSweb, Inc.
PFSW
| $6.55M | ﹤0.01% |
788,800
+60,000
| +8% | +$483K |
|
Similar funds
Wellington Management Group's Q2 2014 Portfolio in Review
As of Q2 2014, Wellington Management Group held 2,343 positions worth $372B, up 3.2% from $360B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2014 filing shows 204 new, 793 increased, 921 reduced and 197 closed positions. Its largest new stake was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M. The largest sale was Teva Pharmaceuticals, an estimated $937M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2014 buy was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M.
- Wellington Management Group added most to Bristol-Myers Squibb in Q2 2014, an estimated $1.52B increase.
- Wellington Management Group's biggest Q2 2014 reduction was Teva Pharmaceuticals, cutting an estimated $937M.
- Wellington Management Group fully exited lululemon athletica in Q2 2014, selling an estimated $456M.
- Wellington Management Group's ten largest holdings make up 15% of its $372B portfolio in Q2 2014.
- Wellington Management Group opened 204 new positions and closed 197 in Q2 2014.
- Wellington Management Group's portfolio value rose 3.2% quarter-over-quarter to $372B.
Based on Wellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.